ConductScience.org, home

Paper20133017

Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.

Glodzik L and 12 others. Neurobiol Aging, 2011. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders. Papers, record 20133017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20133017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.
PubMed
Journal
Neurobiol Aging
PubMed
Year
2011
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.24
iCite
Revised in PubMed
2025-05-29
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Glodzik LLidia
2de Santi SSusan
3Tsui WHWai Hon
4Mosconi LLisa
5Zinkowski RRaymond
6Pirraglia EElizabeth
7Wang HYHui Yu
8Li YYi
9Rich KEKenneth E
10Zetterberg HHenrik
11Blennow KKaj
12Mehta PPankaj
13de Leon MJMony J

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Memory DisordersMajor topic
Temporal LobeMajor topic
tau ProteinsMajor topic
Aged
Aged, 80 and over
Atrophy
Biomarkers
Cognition Disorders
Female
Follow-Up Studies
Humans
Longitudinal Studies
Male
Middle Aged
Phosphorylation

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AG022374NIA NIH HHSUnited StatesR01AG022374PubMed and NIHNIH RePORTER
R01 AG013616NIA NIH HHSUnited StatesR01AG013616PubMed and NIHNIH RePORTER
P30 AG008051NIA NIH HHSUnited StatesP30AG008051PubMed and NIHNIH RePORTER
R01 AG012101NIA NIH HHSUnited StatesR01AG012101PubMed and NIHNIH RePORTER
AG022374NIA NIH HHSUnited StatesR01AG022374PubMed and NIHNIH RePORTER
AG08051NIA NIH HHSUnited StatesP30AG008051PubMed and NIHNIH RePORTER
AG12101NIA NIH HHSUnited StatesR01AG012101PubMed and NIHNIH RePORTER

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112485966Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation2002https://conductscience.org/library/papers/12485966PubMed
28933812Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders.J Comput Assist Tomogr1996https://conductscience.org/library/papers/8933812PubMed
317698783CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.Neurology2007https://conductscience.org/library/papers/17698783PubMed
418692273Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.Neurobiol Aging2010https://conductscience.org/library/papers/18692273PubMed
516966547Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI.Neurology2006https://conductscience.org/library/papers/16966547PubMed
618590359Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.Neuropsychology2008https://conductscience.org/library/papers/18590359PubMed
717254013Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.J Neurochem2007https://conductscience.org/library/papers/17254013PubMed
812482066Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias.Neuroimage2002https://conductscience.org/library/papers/12482066PubMed
910863026Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.Neurosci Lett2000https://conductscience.org/library/papers/10863026PubMed
1019260027Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.Ann Neurol2009https://conductscience.org/library/papers/19260027PubMed
1117242334Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.Neurology2007https://conductscience.org/library/papers/17242334PubMed
1212584433Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.Dement Geriatr Cogn Disord2003https://conductscience.org/library/papers/12584433PubMed
1317622715Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.Dement Geriatr Cogn Disord2007https://conductscience.org/library/papers/17622715PubMed
1414657306Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging.Radiology2003https://conductscience.org/library/papers/14657306PubMed
1517210801Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.Arch Neurol2007https://conductscience.org/library/papers/17210801PubMed
161759558Neuropathological stageing of Alzheimer-related changes.Acta Neuropathol1991https://conductscience.org/library/papers/1759558PubMed
1715753419Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.Neurology2005https://conductscience.org/library/papers/15753419PubMed
1819280686Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.Neuroimage2009https://conductscience.org/library/papers/19280686PubMed
1910860804Voxel-based morphometry--the methods.Neuroimage2000https://conductscience.org/library/papers/10860804PubMed
2015623699Atrophy rate in medial temporal lobe during progression of Alzheimer disease.Neurology2004https://conductscience.org/library/papers/15623699PubMed

See all 36 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42583778CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults.Alzheimers Dement2026https://conductscience.org/library/papers/42583778PubMed
42395347Striatal functional connectivity alterations in mild cognitive impairment subtypes defined by CSF A/T biomarkers.Front Aging Neurosci2026https://conductscience.org/library/papers/42395347PubMed
39707506Paradoxical attenuation of early amyloid-induced cognitive impairment and synaptic plasticity in an aged APP/Tau bigenic rat model.Acta Neuropathol Commun2024https://conductscience.org/library/papers/39707506PubMed
39095921Neuronal double-stranded DNA accumulation induced by DNase II deficiency drives tau phosphorylation and neurodegeneration.Transl Neurodegener2024https://conductscience.org/library/papers/39095921PubMed
36768490The Effect of the Tau Protein on D. melanogaster Lifespan Depends on GSK3 Expression and Sex.Int J Mol Sci2023https://conductscience.org/library/papers/36768490PubMed
36448621Blood Pressure Variability and Cognitive Decline: A Post Hoc Analysis of the SPRINT MIND Trial.Am J Hypertens2023https://conductscience.org/library/papers/36448621PubMed
35633431Testosterone, cognitive decline and dementia in ageing men.Rev Endocr Metab Disord2022https://conductscience.org/library/papers/35633431PubMed
32588967Extracellular vesicle biomarkers of Alzheimer's disease associated with sub-clinical cognitive decline in late middle age.Alzheimers Dement2020https://conductscience.org/library/papers/32588967PubMed
32178724A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.Alzheimers Res Ther2020https://conductscience.org/library/papers/32178724PubMed
31403948A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging.J Alzheimers Dis2019https://conductscience.org/library/papers/31403948PubMed
31371787β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly.Sci Rep2019https://conductscience.org/library/papers/31371787PubMed
29563868Glycerophospholipid Supplementation as a Potential Intervention for Supporting Cerebral Structure in Older Adults.Front Aging Neurosci2018https://conductscience.org/library/papers/29563868PubMed
29036824Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.J Alzheimers Dis2017https://conductscience.org/library/papers/29036824PubMed
28229128Repetitive head impact exposure and later-life plasma total tau in former National Football League players.Alzheimers Dement (Amst)2017https://conductscience.org/library/papers/28229128PubMed
27903332Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years Prior.J Int Neuropsychol Soc2016https://conductscience.org/library/papers/27903332PubMed
27842175Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.JAMA Neurol2017https://conductscience.org/library/papers/27842175PubMed
27064267Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.JAMA Neurol2016https://conductscience.org/library/papers/27064267PubMed
26416094Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study.J Int Neuropsychol Soc2015https://conductscience.org/library/papers/26416094PubMed
26394023Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.Neuropsychologia2015https://conductscience.org/library/papers/26394023PubMed
24795085Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.Alzheimers Dement2015https://conductscience.org/library/papers/24795085PubMed

See all 30 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20133017

GET https://conductscience.org/api/papers/v1/20133017/references?page=2